GenFleet Therapeutics (Shanghai) Inc. (“GenFleet-B”) filed its Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in its share capital structure during the month.

Key highlights

1. Issued Share Capital • H shares listed on the Hong Kong Stock Exchange: 338.03 million shares, par value RMB 0.1 each, representing registered share capital of RMB 33.80 million. • Unlisted ordinary shares: 32.34 million shares, par value RMB 0.1 each, representing registered share capital of RMB 3.23 million. • Total issued share capital remained RMB 37.04 million. • The company held zero treasury shares at both the beginning and end of the month.

2. Capital Movements • No issuance, cancellation, conversion, or repurchase of shares took place. • No outstanding share options, warrants, convertibles, or other equity instruments were reported.

3. Public Float • The company confirmed compliance with the Hong Kong Main Board’s minimum public float threshold. As at 30 June 2026, at least 19.86 % of GenFleet-B’s H shares were held by the public, satisfying the exchange requirement.

4. Governance • The return was submitted to Hong Kong Exchanges and Clearing Limited on 6 July 2026 and signed by Joint Company Secretary Zhang Wei.

The update underscores a month of capital stability for GenFleet-B with continued adherence to listing regulations.